Synopsis

Source of validity: Traditional
Rating (out of 5): 2

Plantago species, particularly Plantago major and Plantago lanceolata, have a long history of use in traditional medicine systems for respiratory ailments, including coughs, bronchitis, and other pulmonary complaints. Their use for conditions resembling Chronic Obstructive Pulmonary Disease (COPD) is rooted in these traditions, especially in European, Asian, and Native American herbal practices. The leaves are typically used as teas, syrups, or extracts believed to soothe mucous membranes, reduce inflammation, and promote expectoration.

Scientific research into Plantago for COPD specifically is limited and largely preclinical. Some in vitro and animal studies suggest anti-inflammatory and antioxidant effects, and limited clinical trials indicate possible benefits in reducing cough or mild bronchial irritation. However, these studies are not robust, are generally of poor methodological quality, and do not directly address COPD as defined in modern medical terms. No high-quality, large-scale clinical trials have demonstrated Plantago’s efficacy in treating or managing COPD. Thus, while the plant has a strong historical and traditional basis for use in respiratory conditions, scientific validation for its use in COPD is weak and insufficient for formal recommendation.

More about Plantago (unspecified)
More about Chronic Obstructive Pulmonary Disorder

Other ingredients used for Chronic Obstructive Pulmonary Disorder

Other health conditions supported by Plantago (unspecified)

Products containing Plantago (unspecified)